Drug Pipeline

BI 1291583 Clinical Trials

Name: BI 1291583 clinical trials — 4 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Phase 3

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-10	NCT07023354 A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver…	date change Primary completion pushed: 2026-08-01 -> 2026-09-17
2026-06-10	NCT07023354 A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver…	date change Completion pushed: 2026-08-01 -> 2026-09-17

Active Studies by Phase

Phase 3

Phase 2

Phase 1

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT06872892	The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With…	Bronchiectasis	Recruiting
Phase 2
NCT05846230	Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With…	Bronchiectasis	Active, Not Recruiting
Phase 1
NCT07023354	A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver…	Healthy	Recruiting
NCT07531628	A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants	Healthy	Not Yet Recruiting

Sponsors Running BI 1291583 Trials

Boehringer Ingelheim (4)

Get alerts when BI 1291583 trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.